Molecular Biology of Polycythemia and Thrombocytosis

Part of paid clinical trials in Salt Lake City, Utah.

Sponsor
University of Utah
Study ID
NCT00722527
Status
Recruiting
Apply to this trial

Conditions

  • Polycythemia
  • Thrombocytosis

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

Our study is designed to characterize the clinical picture and genetic pattern of Polycythemia and Thrombocytosis. The purpose of this project is to find a gene and its mutation that causes these disorders. When this is accomplished, new therapies to control and eventually cure the disorder can be designed.

Key Dates

Start date
Jul 31, 2006
Status verified
Mar 2026
Primary completion
Jul 31, 2028
Completion
Jul 31, 2028

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: Affected Population
    Subjects with an elevated hemoglobin concentration or an elevated platelet count

Primary Outcome Measure

Identify the molecular defect of Polycythemic and Thrombocythemic disorders [ Time Frame: Weekly ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of UtahSalt Lake CityUtah84132
Josef T Prchal, MD
[email protected]
801-581-4220
Soo Jin Kim, MS
[email protected]
801-213-4379
Josef T Prchal, MD (PRINCIPAL_INVESTIGATOR)
Neeraj Agarwal, MD (SUB_INVESTIGATOR)
Dong Yoon, PhD (SUB_INVESTIGATOR)
Tatum Simonson, PhD (SUB_INVESTIGATOR)

Find similar trials in Salt Lake City, UT

By research site
University of Utah· Salt Lake City, UT

Related Studies